Regulation of autoimmunity by proinflammatory cytokines

Current Opinion in Immunology

Volumn 10, Issue 6, 1998, Pages 669-676

  Cope, Andrew P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; AUTOIMMUNITY; DISEASE SEVERITY; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE;

EID: 0032401777     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(98)80087-3     Document Type: Article

References (59)

1. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol. 10:1992;411-452.
2. Cope A, Ettinger R, McDevitt H. The role of TNFα and related cytokines in the development and function of the autoreactive T-cell repertoire. of special interest Res Immunol. 148:1997;307-312 This review discusses the possible mechanisms for the apparently paradoxical effects of TNF injections during the neonatal and adult period in NOD mice. The discussion focuses on, firstly, the developmental lymphoid system anomalies arising through chronic TNF blockade and, secondly, the possibility that chronic TNF treatment targets TCR signaling in developing thymocytes during the neonatal period but targets effector T cells in the adult. In thymocytes, attenuation of TCR signaling would impair negative selection of autoreactive T cells and lead to accelerated disease; the same process of suppression would depress effector function in established pathogenic T cells in the adult, leading to disease suppression (see also [10,42]).
3. Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH. Autocrine T-cell suicide mediated by APO-1/CD95. Nature. 373:1995;438-441.
4. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature. 373:1995;441-444.
5. Ju S-T, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature. 373:1995;444-448.
6. Tartaglia LA, Ayres TM, Wong GHW, Goeddel DV. A novel domain within the 55kd TNF receptor signals cell death. Cell. 74:1993;845-853.
7. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature. 377:1995;348-351.
8. Speiser DE, Sebzda E, Ohteki T, Bachmann MF, Pfeffer K, Mak TW, Ohashi PS. Tumour necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo. Eur J Immunol. 26:1996;3055-3060.
9. Sytwu HK, Liblau RS, McDevitt HO. The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity. 5:1996;17-30.
10. Sarin A, Conan-Cibotti M, Henkart PA. Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts. J Immunol. 155:1995;3716-3718.
11. Cohen PL, Eisenberg RA. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol. 9:1991;243-269.
12. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G. Immune and inflammatory responses in TNFα-deficient mice: a central requirement of TNFα in the formation of primary B cell follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med. 184:1996;1397-1411.
13. Pasparakis M, Alexopoulou L, Grell M, Pfizenmaier K, Bluethmann H, Kollias G. Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor. Proc Natl Acad Sci USA. 94:1997;6319-6323.
14. -/- mice also show a late, anomalous response to heat-killed Corynebacterium parvum - suggesting that TNF plays an important role in limiting the extent and duration of inflammatory responses.
15. high phenotype, unfractionated synovial fluid T cells from patients with RA fail to undergo apoptosis; neutrophil apoptosis, by contrast, is clearly evident. When removed from the inflammatory environment, purified T cells die if untreated but cells can be rescued - with IL-2, IL-15 or using co-culture with fibroblasts or fibroblast-conditioned meidum. This protection is also integrin mediated. What is intriguing is that defective T cell apoptosis is particular to RA, because no defect can be identified when T cells from patients with gout are studied.
16. Vella AT, McCormack JE, Linsley PS, Kappler JW, Marrack P. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity. 2:1995;261-270.
17. + TCR-transgenic T cells from DO11.10 mice lead to transient accumulation of T cells in lymphoid tissues (as determined with anticlonotypic antibodies) which is increased significantly not only by LPS but also by three consecutive injections of recombinant TNF or IL-1 but not IL-6. These effects are antigen dependent. Adjuvants may work through the same mechanisms.
18. Liu Z-G, Hsu H, Goeddel DV, Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell. 87:1996;565-576.
19. Beg AA, Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science. 274:1996;782-784.
20. Wang C-Y, Mayo MW, Baldwin AS Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science. 274:1996;784-787.
21. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-α-induced apoptosis by NF-κB. Science. 274:1996;787-789.
22. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today. 13:1992;151-153.
23. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α J Exp Med. 179:1994;1109-1118.
24. Jacob CO, McDevitt HO. Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis. Nature. 331:1988;356-358.
25. Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med. 179:1994;305-310.
26. Gordon C, Ranges GE, Greenspan JS, Wofsy D. Chronic therapy with recombinant tumor necrosis factor-α in autoimmune NZB/W F1 mice. Clin Immunol Immunopathol. 52:1989;421-434.
27. Zhou T, Edwards CK, Yang P, Wang Z, Bluethmann H, Mountz JD. Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor 1. J Immunol. 156:1996;2661-2665.
28. Gordon C, Wofsy D. Effects of recombinant murine tumor necrosis factor-α on immune function. J Immunol. 144:1990;1753-1758.
29. Cope AP, Londei M, Chu NR, Cohen SB, Elliott MJ, Brennan FM, Maini RN, Feldmann M. Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis. J Clin Invest. 94:1994;749-760.
30. Lorenz HM, Antoni C, Valerius T, Repp R, Grunke M, Schwerdtner N, Nusslein H, Woody J, Kalden JR, Manger B. In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects. J Immunol. 156:1996;1646-1653.
31. Lai N-S, Lan J-L, Yu C-L, Lin R-H. Role of tumor necrosis factor-α in the regulation of activated synovial T cell growth: downregulation of synovial T cells in rheumatoid arthritis. Eur J Immunol. 25:1995;3243-3248.
32. Cope AP, Liblau RS, Yang XD, Congia M, Laudanna C, Schreiber RD, Probert L, Kollias G, McDevitt HO. Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. of special interest J Exp Med. 185:1997;1573-1584 This series of experiments examines the function of TCR-transgenic T cells exposed to TNF for prolonged periods in vitro or in vivo, following stimulation with specific peptide. The results show that chronic TNF effects are dose- and time-dependent; Th1 and Th2 responses are impaired; effects are reversible with anti-TNF antibodies; and chronic TNF attenuates early TCR signaling events. Peptide-specific responses are also depressed in TCR x human TNF-globin double-transgenic mice, implying a role for sustained signaling via the p55 TNF-R. Interestingly, the effects in B10.D2 and Balb/c strains are different.
33. Grewal IS, Grewal KD, Wong FS, Picarella DE, Janeway CA Jr, Flavell RA. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. J Exp Med. 184:1996;1963-1974.
34. lo is diminished in mice that express both TNF and LACK in the pancreas.
35. DiCosmo BF, Picarella D, Flavell RA. Local production of human IL-6 promotes insulitis but retards the onset of insulin-dependent diabetes mellitus in non-obese diabetic mice. Int Immunol. 6:1994;1829-1837.
36. Rincon M, Anguita J, Nakamura T, Fikrig E, Flavell RA. Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. of special interest J Exp Med. 185:1997;461-469 Since macrophage-derived IL-12 production is thought to be pivotal in initiating the differentiation of Th1 cells (together with IFN-γ), the authors examine whether macrophage products could also be responsible for providing analogous signals to Th2 precursors to induce IL-4 production. Their hypothesis is substantiated with regard to IL-6 by experiments using anti-IL-6 or anti-IL-6-R mAbs and in experiments where Il-6 can restore IL-4 production by T cells from IL-6-deficient mice. Interestingly, data indicate that IL-6 induces IL-4 gene expression; this possibly occurs through the presence - in the IL-4 gene 5′ region - of functional binding sites for CCAAT/enhancer-binding protein (C/EBP)-like transcription factors, which include the nuclear factor for IL-6 (NF-IL-6).
37. 2+ fluxing is impaired in T cells from RA patients following TCR/CD3 ligation, the authors demonstrate convincingly that activation-induced tyrosine phosphorylation is impaired in synovial T cells; this most notably affects the p38 phosphoprotein but also the TCRζ chain, whose expression is also reduced. CD3ε expression is spared. The intriguing link between redox status and TCRζ chain expression is discussed.
38. Liu J, Marino MW, Wong G, Grail D, Dunn A, Bettadapura J, Slavin AJ, Old L, Bernard CC. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. of outstanding interest Nat Med. 4:1998;78-83 This study, together with [14], provides unequivocal evidence that TNF, though not obligatory for disease induction, has potent anti-inflammatory effects in autoimmune and inflammatory responses that appear to be mediated through p55 TNF-R. Presumably lymphotoxin (LT) cannot compensate, nor is responsible, because anti-LT antibodies do not influence the disease phenotype. The striking observation is that the TNF-null mutation converts a resistant strain to a susceptible one.
39. Probert L, Akassoglou K, Kassiotis G, Kollias G. TNF and receptors in CNS function: friend or foe [abstract]. J Interferon Cytokine Res. 18:1998;A83.
40. Probert L, Akassoglou K, Kassiotis G, Kollias G. TNF and receptors in CNS function: friend or foe [abstract]. J Interferon Cytokine Res. 18:1998;A92.
41. Marino MW, Noguchi Y, Wada H, Ritter E, Jungbluth A, Richards E, Old LJ. Anti-inflammatory activities of TNF [abstract]. J Interferon Cytokine Res. 18:1998;A81.
42. van Oosten BW, Barkhof F, Truyen L, Boringa JB, Bertelsmann FW, von Blomberg BM, Woody JN, Hartung HP, Polman CH. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology. 47:1996;1531-1534.
43. Berger S, Chandra R, Ballo H, Hildenbrand R, Stutte HJ. Immune complexes are potent inhibitors of interleukin-12 secretion by human monocytes. Eur J Immunol. 27:1997;2994-3000.
44. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 14:1996;397-440.
45. Bohm SK, Grady EF, Bunnett NW. Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. of special interest Biochem J. 322:1997;1-18 This is a comprehensive and detailed review which focuses on the principal mechanisms by which signaling through G-protein-coupled receptors such as neurotransmitters, chemokines and prostanoids can be attenuated.
46. Yeh WC, Shahinian A, Speiser D, Kraunus J, Billia F, Wakeham A, de la Pompa JL, Ferrick D, Hum B, Iscove N, et al. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity. 7:1997;715-725.
47. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity. 8:1998;297-303.
48. Cope AP, Aderka D, Wallach D, Kahan M, Chu NR, Brennan FM, Feldmann M. Soluble TNF receptor production by activated T lymphocytes: differential effects of acute and chronic exposure to TNF. Immunology. 84:1995;21-30.
49. Petricoin EF III, Ito S, Williams BL, Audet S, Stancato LF, Gamero A, Clouse K, Grimley P, Weiss A, Beeler J, et al. Antiproliferative action of interferon-alpha requires components of T-cell-receptor signalling. of outstanding interest Nature. 390:1997;629-632 Although IFN receptors signal through the Janus kinase/signal transducer and activator of transcription (JAK/STAT) signal transduction pathways, this illuminating study demonstrates that the mechanism for the growth-suppressing effects of IFN-α on human peripheral blood T cells or Jurkat cells involves the sequential recruitment of CD45, lck and ZAP-70 to the IFN-R complex. Consistent with this, Jurkat cells with defective CD45, lck or ZAP-70 are resistant to IFN-α-mediated inhibitory effects, while JAK/STAT and antiviral responses are preserved in these mutants.
50. Bacon KB, Szabo MC, Yssel H, Bolen JB, Schall TJ. RANTES induces tyrosine kinase activity of stably complexed p125FAK and ZAP-70 in human T cells. J Exp Med. 184:1996;873-882.
51. Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha-Orbea H. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc Natl Acad Sci USA. 87:1990;968-972.
52. 2+ fluxing by TCRξ-negative T cells is still higher than responses from control subjects. The patterns of responses defined in prospective studies are independent of drug treatment or disease activity, suggesting that the defect may be genetic - possibly linked to the locus for TCRξ on chromosome 1.
53. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA. 91:1994;4854-4858.
54. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 271:1996;665-668.
55. Satoh J, Seino H, Abo T, Tanaka SI, Shintani S, Ohta S, Tamura K, Sawai T, Nobunaga T, Ohteki T, et al. Recombinant human tumor necrosis factor α suppresses autoimmune diabetes in non-obese diabetic mice. J Clin Invest. 84:1989;1345-1348.
56. Jacob CO, Aiso S, Schreiber RD, McDevitt HO. Monoclonal anti-tumor necrosis factor antibody renders non-obese diabetic mice hypersensitive to irradiation and enhances insulitis development. Int Immunol. 4:1992;611-614.
57. Satoh J, Seino H, Shintani S, Tanaka SI, Ohteki T, Masuda T, Nobunaga T, Toyota T. Inhibition of type I diabetes in BB rats with recombinant human tumor necrosis factor-α J Immunol. 145:1990;1395-1399.
58. Higuchi Y, Herrera P, Muniesa P, Huarte J, Belin D, Ohashi P, Aichele P, Orci L, Vassalli JD, Vassalli P. Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes. J Exp Med. 176:1992;1719-1731.
59. Picarella DE, Kratz A, Li CB, Ruddle NH, Flavell RA. Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice. J Immunol. 150:1993;4136-4150.